Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
How Managing Provider Data Can Make a Positive Impact on the Claims Process
This is the third and final article in a series about provider data quality.
Workers' Comp
Blog
What Will Opioid Legislation do for Pharmacy and Opioid Risk Management?
In October 2018, Congress passed H.R.6, the “Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communitie
Mitchell
Article
Frequency and Severity Trends in Auto Claims
In late 2018, three of the largest auto insurers in the United States reported decreased frequency and increased severity in third quarter auto cla
Mitchell
Article
Changing Consumer Expectations: What Workers' Compensation Can Learn from the Healthcare Industry
Workers' Comp
News Release
WorkCompCentral.com: Focus Intensifies on Diagnostic Imaging Quality (subscription required)
Medical imaging can be a key step in the diagnosis and treatment of an injured worker, but a recent debate has raised questions about whether
Mitchell
News Release
Mitchell Adds Dynamic Advanced Driver-Assistance Systems (ADAS) Recalibrations within Mitchell Diagnostics
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the